Predicta Biosciences Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$24M
- Investors
-
12
Predicta Biosciences General Information
Description
Developer of an oncology technology platform designed for cancer diagnosis and treatment. The company's platform specializes in integrating multi-omics and liquid biopsy technologies with non-invasive diagnostics, focusing on multiple myeloma to determine the likelihood of a patient responding to immunotherapies, enabling healthcare firms to offer non-invasive blood-based diagnostics that replace bone marrow biopsies and guide optimal immunotherapy decisions.
Contact Information
Website
www.predictabiosciences.comCorporate Office
- 750 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 750 Main Street
- Cambridge, MA 02139
- United States
Predicta Biosciences Timeline
Predicta Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A2) | 01-Oct-2025 | $24M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A1) | 20-Jun-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Sep-2024 | Completed | Generating Revenue |
Predicta Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Predicta Biosciences Comparisons
Industry
Financing
Details
Predicta Biosciences Competitors (32)
One of Predicta Biosciences’s 32 competitors is Certis Oncology Solutions, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Certis Oncology Solutions | Venture Capital-Backed | San Diego, CA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| PNP Therapeutics | Formerly VC-backed | Birmingham, AL | ||||
| InSilico Medicine Cayman | Formerly VC-backed | Hong Kong, Hong Kong | ||||
| Adaptive Biotechnologies | Formerly VC-backed | Seattle, WA |
Predicta Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Predicta Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Predicta Biosciences Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Binney Street Capital | Corporate Venture Capital | Minority | ||
| Impact Assets | Impact Investing | Minority | ||
| Lightchain Capital | Venture Capital | Minority | ||
| Mass General Brigham Ventures | Venture Capital | Minority | ||
| Myeloma Solutions Fund | Corporation | Minority |
Predicta Biosciences FAQs
-
When was Predicta Biosciences founded?
Predicta Biosciences was founded in 2023.
-
Where is Predicta Biosciences headquartered?
Predicta Biosciences is headquartered in Cambridge, MA.
-
What is the size of Predicta Biosciences?
Predicta Biosciences has 11 total employees.
-
What industry is Predicta Biosciences in?
Predicta Biosciences’s primary industry is Biotechnology.
-
Is Predicta Biosciences a private or public company?
Predicta Biosciences is a Private company.
-
What is the current valuation of Predicta Biosciences?
The current valuation of Predicta Biosciences is .
-
What is Predicta Biosciences’s current revenue?
The current revenue for Predicta Biosciences is .
-
How much funding has Predicta Biosciences raised over time?
Predicta Biosciences has raised $29.2M.
-
Who are Predicta Biosciences’s investors?
Binney Street Capital, Impact Assets, Lightchain Capital, Mass General Brigham Ventures, and Myeloma Solutions Fund are 5 of 12 investors who have invested in Predicta Biosciences.
-
Who are Predicta Biosciences’s competitors?
Certis Oncology Solutions, Foundation Medicine, PNP Therapeutics, InSilico Medicine Cayman, and Adaptive Biotechnologies are some of the 32 competitors of Predicta Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
